Skip to content
healthcare.dev
Get a free key

Medroxyprogesterone Acetate Injectable Suspension

NDC 24201-150, medroxyprogesterone acetate, injection, suspension, from Hikma Pharmaceuticals USA Inc..

Product NDC
24201-150
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214309
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24201-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEDROXYPROGESTERONE ACETATE150 mg/mL

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
24201-150-01242010150011 VIAL in 1 CARTON (24201-150-01) / 1 mL in 1 VIAL (24201-150-00)
24201-150-252420101502525 VIAL in 1 CARTON (24201-150-25) / 1 mL in 1 VIAL (24201-150-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0476eac5-d96c-4910-aa86-1ddeeefefe50

Use it

Look up 24201-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24201-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24201-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.